Azitra Inc Stock Today
| AZTR Stock | 0.23 -0.01 -4.17% |
Performance 0High 4 · Mild | Odds Of Distress HighLow 77 · Very High |
The current session places Azitra at $0.23, reflecting a 4.17% decrease in today's trading after opening at $0.24. Azitra presents a substantially elevated probability of financial distress, with model-implied probability near 77%. Azitra has produced modest risk-adjusted performance over the past 90 trading days. The performance scores are measured across the period from February 9, 2026 to May 10, 2026. Learn more.
IPO Date 16th of June 2023 | Asset Type Stock | Category Healthcare | Classification Health Care |
Follow Valuation Profit Patterns Odds of Bankruptcy
Azitra Inc (AZTR) is listed on NYSE MKT Exchange in USA. Azitra operates within the Biotechnology segment. Azitra Inc remains a nano-cap name by market cap, with total market value estimated at $3.79 million versus biotechnology companies. Supplemental capitalization data includes enterprise value near $2.5 million and about 16.19 million shares outstanding. Azitra has 557,165 shares sold short (0.02 days to cover). Azitra is a research-driven pharmaceutical developer where revenue is driven by pipeline advancement, approvals, and patent-protected revenue. AZTR has a beta of -0.4891. As returns on the market increase, returns on Azitra tend to move in the opposite direction, though by a smaller magnitude. During a bear market, however, Azitra tends to outperform the market. Azitra financial stability analysis Ownership Allocation Azitra displays a 3.38% of its outstanding shares held by insiders and 1.57% owned by institutional holders.
Check Azitra Ownership Details Check how we calculate scores
Stock Notable Updates
| Legal Name | Azitra Inc |
| President CEO & Director | Francisco Salva |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE AMEX Composite, Health Care, Biotechnology, Biotechnology, Healthcare, (View all Sectors) |
Azitra Inc (AZTR) recorded an Operating Profit Margin of -160017.0%, a Return On Assets of -0.2%, and a Return On Capital Employed of -0.3%. Operational scale and capital discipline leave Azitra Inc with pressured financial positioning. The earnings picture reflects near-term margin compression relative to deployed assets.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.96 | 0.92 |
|
| |||||
| Total Current Liabilities | $1.12 billion | $1.07 billion |
|
| |||||
| Non Current Liabilities Total | $164 million | $156.19 million |
|
| |||||
| Total Assets | $5.28 billion | $5.03 billion |
|
| |||||
| Total Current Assets | $3.17 billion | $3.02 billion |
|
|
Current Assets
Azitra Inc (AZTR) recorded $0.07 in Intangibles To Total Assets, $5.3 billion in Total Assets, and a Return On Assets of -0.2%. Additional disclosures note a Return On Tangible Assets of -0.2%, relevant to Azitra Inc's position within the Health Care sector.
Azitra Historical Income Statement
Net Interest Income stood at $62,622 as of December 31, 2025. Meanwhile, Selling General Administrative is broadly unchanged at $6.13 billion, while EBIT remains stable at $-10.94 million. View More FundamentalsAzitra Inc Against Markets
| NYA | 0.30 | ||||
| AZTR | 4.17 |
| Competition | Compare Correlations |
Stock Overview, Methodology & Data Sources
Azitra is publicly available via the NYSE MKT Exchange. Headquarters are in 21 Business Park Drive, Branford, CT, United States, 06405. Key reported metrics include market cap 3.79 million, P/B 1.09. Azitra operates in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Reported fundamentals are aligned with observed market behavior. Historical price behavior shows relatively contained downside volatility compared to broader equities.
Methodology
Unless otherwise specified, financial data for Azitra Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Azitra (USA Stocks:AZTR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. All analytics presented are generated using Macroaxis quantitative models that incorporate financial statement analysis, market data, and risk metrics to ensure consistency and comparability. Assumptions: This report is built using public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Normalization for analytical consistency may introduce small timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Azitra Inc may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board
Azitra Corporate Executives
Governance context around Azitra Inc provides another way to assess whether decision-making power is balanced, accountable, and aligned with shareholder priorities. Institutions hold about 1.57% of shares while insiders own roughly 3.38%.
| Norman Staskey | CFO & Treasurer | Profile | |
| Mr MPH | COO, CoFounder | Profile | |
| Travis MPH | Co-Founder, COO, Secretary & Director | Profile | |
| Dr MPH | COO, CoFounder | Profile |
Already Invested in Azitra Inc?
This investing note explains the basic risk concepts to review before opening a position. It highlights why raw returns should be read alongside volatility and benchmark comparison. The danger of trading Azitra Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Azitra is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a riskier asset than Azitra. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Azitra Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-month bill.
Additional Tools for Azitra Stock Analysis
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your accountPortfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfoliosTop Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchangesPerformance AnalysisCheck effects of mean-variance optimization against your current asset allocationPrice Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instrumentsEfficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market.Pattern RecognitionUse different Pattern Recognition models to identify potential trend changes across multiple global exchangesEquity ValuationEstimate intrinsic value of public entities based on technical and fundamental dataPair CorrelationCompare performance and examine fundamental relationship between any two equity instruments